Andrew leads the organisation, structuring, development and financing of early stage and developing business ventures from inception through to commercialisation and investor value realisation and exit. He brings management, business planning, strategic, operating skills and experience to AlgaeCytes.
Andrew structures, negotiates, completes and implements essential and transformative business transactions, including licenses, joint ventures, mergers, acquisitions and business dispositions, and equity and debt financings. He serves and has served as a director, management team member or otherwise primarily for companies in the biotech, cleantech environmental, basic energy, and natural resources sectors in Europe, Asia, and the U.S.
Before these commercial roles, Andrew spent 25 years in an international M&A legal practice and was partner in well-known international law firms.
Andrew is a Yale graduate.